Cargando…
Discovery of 4-(2-(dimethylamino)ethoxy)benzohydrazide derivatives as prospective microtubule affinity regulating kinase 4 inhibitors
Microtubule affinity regulating kinase 4 (MARK4) is a Ser/Thr kinase, considered as a potential drug target for cancer, diabetes and neurodegenerative diseases. Due to its significant role in the development and progression of cancer, different in-house libraries of synthesized small molecules were...
Autores principales: | Khan, Nashrah Sharif, Khan, Parvez, Inam, Afreen, Ahmad, Kamal, Yousuf, Mohd., Islam, Asimul, Ali, Sher, Azam, Amir, Husain, Mohammad, Hassan, Md. Imtaiyaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054212/ https://www.ncbi.nlm.nih.gov/pubmed/35520423 http://dx.doi.org/10.1039/d0ra00453g |
Ejemplares similares
-
Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones
por: Voura, Maria, et al.
Publicado: (2019) -
4-(Dimethylamino)benzohydrazide
por: Kelley, Steven P., et al.
Publicado: (2020) -
Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies
por: Khan, Parvez, et al.
Publicado: (2017) -
N-[4-(Dimethylamino)benzylidene]-4-ethoxyaniline
por: Wang, Qiang, et al.
Publicado: (2007) -
Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole
Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based
Cancer Therapy
por: Peerzada, Mudasir Nabi, et al.
Publicado: (2020)